![caused a strong and dose-dependent inhibition of anti-IgE–induced cells and basophils (maximally 73% and 82%, respectively, mast cell tryptase (maximally 75%) and a less pronounced of calcium ionophore plus phorbol myristate acetate–induced at 100 nmol/L pimecrolimus). [1] topical SDZ ASM 981 was as effective as the ultrapotent and when compared with a series of commercial](/img/pdfimg/E1KS5003/E1KS5003-001.jpg)
caused a strong and dose-dependent inhibition of anti-IgE–induced cells and basophils (maximally 73% and 82%, respectively, mast cell tryptase (maximally 75%) and a less pronounced of calcium ionophore plus phorbol myristate acetate–induced at 100 nmol/L pimecrolimus). [1] topical SDZ ASM 981 was as effective as the ultrapotent and when compared with a series of commercial